VitaSpring Biomedical delays quarterly Form 10-Q filing for period ended July 31, 2026 - VSBC News | RalliesVitaSpring Biomedical delays quarterly Form 10-Q filing for period ended July 31, 2026
V
VSBC• Form 10-Q filing delayed after management transition
- VitaSpring Biomedical filed a Form 12b-25 to delay its quarterly Form 10-Q for the period ended July 31, 2026.
- Management transition on Sept. 7 slowed review of financial statements, disclosure controls and required certifications.
- Limited accounting staff, prior internal-control weakness and Inline XBRL work contributed to the missed filing deadline.
- Filing targeted within five calendar days of the original due date.
- Net loss expected at about $155,817 for the quarter, versus $110,845 a year earlier; six-month loss seen at $231,661.
•
